Monday, September 24, 2018, SCAI submits comments to CMS on the 2019 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule urging CMS to create a mechanism for hospitals to differentiate reporting with a differential in reimbursement for drug-coated balloons as compared to traditional PTA balloons used in lower extremity revascularization procedures. SCAI also provides guidance regarding ASC payment for diagnostic coronary categorization procedures.

SCAI Comment Letter

Editorial: Centers for Medicare & Medicaid Services’decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence

Editorial: Public Health Impact of the Centers for Medicare and Medicaid Services Decision on Pass-Through Add-On Payments for Drug-Coated Balloons